from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3601c/panD

LFCtreatmentdescriptionclass of inhibitor

0.108

Amikacinug/mL Amikacintranslation

0.435

Cap5-10ug/mL Capreomycintranslation

0.505

Rox10-50 ug/mL Roxithromycintranslation

1.363

SM2-5 ug/mL Streptomycintranslation

1.223

Tet5-10 ug/mL Tetracyclinetranslation

-0.811

Rif0.2-5ug/mL Rifampicintranscription

0.067

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.725

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.736

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.128

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.124

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.374

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.851

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.505

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.247

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.483

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.134

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.357

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.417

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.981

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.580

KCN5-20 ug/mL Potassium cyaniderespiration

-1.319

NaN30.2-2 mM Sodium aziderespiration

0.071

Nigericin50 uM Nigericinrespiration

-0.928

TRC10-150 ug/mL Triclosanrespiration

0.566

TRZ10-25 ug/mL Thioridazinerespiration

0.821

Valinomycin0.5-10 uM Valinomycinrespiration

-0.252

ZnSO42 mM ZnSO4respiration

-0.289

menadione6-10 ug/mL Menadionerespiration

0.537

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.145

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.017

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.311

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.173

NRP_1Non-replicating persistence stage 1dosRassociated

0.699

Amp0.2mg/mL AmpicillincellWall

0.095

Cephalexin20-100 ug/mL CephalexincellWall

0.649

Cerulenin0.32-5 ug/mL CerulenincellWall

0.750

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.855

EMB10-20 ug/mL EthambutolcellWall

1.429

Eta12-40 ug/mL EthionamidecellWall

1.799

INH0.2-0.4 ug/mL IsoniazidcellWall

0.835

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.700

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.065

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.494

BZA0.12 mg/mL BenzamidearomaticAmides

-1.063

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.532

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.326

H2O24 mM hydrogen peroxideDNAdamaging

0.318

Levo10 ug/mL LevofloxacinDNAdamaging

0.675

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.695

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.321

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.790

UVUV-irradiationDNAdamaging

-0.609

ARP41-4 ug/mL Antitubercular compound ARP4?

0.470

Antimycin12.5-50 ug/mL Antimycin A?

-0.154

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.220

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.018

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.308

PA8240.2-2 ug/mL PA-824?

-0.931

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.004

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.268

Verapamil50 uM Verapamil?

0.594

mercaptoethanol2 mM 2-Mercaptoethanol?

0.411

methoxatin10-20 ug/mL Methoxatin?